Abstract:ObjectiveTo construct a recombinant Listeria ivanovii (LI) strain that expressed Mycobacterium tuberculosis (MTB) specific antigen protein as a novel multistage tuberculosis (TB) vaccine candidate, and evaluate the biosafety and immunogenicity in mouse model.MethodsT cell epitopes of four genes related to different stages of MTB infection were fused in series to form an antigen gene, i.e. the multistage antigen gene (named msv). Then msv was inserted into the targeting plasmid that contained LI homologous sequences. Recombinant LI strain was obtained by transfecting LI with targeting plasmid and screening the recombinant LI strain that carried msv in the genome after series of homologous gene recombination processes. The growth rate of the recombinant LI strain in vitro was observed and the expression of target protein was verified by Western blot. The 50% lethal dose (LD 50) of the recombinant strain to C57BL/6 mice was measured. Mice were intravenously inoculated with vaccine candidate in dose of 0.1×LD 50.The serum alanine aminotransferase (ALT) levels, bacterial load in organs, and organ pathological sections before and 1, 2, 3, 5, 7, 14 d after vaccination were used to evaluate the safety of vaccine candidate strain. To analyze the immunogenicity of vaccine candidate strain, mice were intravenously inoculated with LI- msv, LI, and NS respectively. Nine days post immunization, the spleens were isolated under sterile conditions and splenocytes were collected and stimulated. Lyphocytes which secret specific cytokines, interferon (IFN)-γ, tumor necrosis factor (TNF)-α and interleukin (IL)-2 were analyzed by flow cytometry.ResultsA recombinant strain named LI- msv which was capable of expressing the multistage TB antigen protein was successfully constructed. The LD 50 value of LI- msv for C57BL/6 mice (i.v.) was 3.3×10 8 CFU. After intravenously immunized the mice, this strain mainly multiplied in the liver and spleen, and was cleared at 7 d post innoculation. Such infection process caused transient pathological damages of the liver and spleen. Results of flow cytometry showed specific IFN-γ + CD4 + and IFN-γ + CD8 +T lymphocytes were successfully induced in LI -msv immunized mice spleen lymphocytes. The frequency of IFN-γ positive CD4 + and CD8 +T cells was significantly higher than those of vector control group and NS control group ( P<0.005). Additionally, the frequency of specific TNF-α + CD4 + T cell in LI -msv immunized group was significantly higher than that of vector control ( P<0.01) and NS control group ( P<0.005), and TNF-α + CD8 + T cell frequency obviously increased than NS control group ( P<0.005).ConclusionsA novel multistage TB vaccine candidate expressing TB multistage antigen based on LI was successfully constructed. This vaccine candidate is safe and can induce specific cellular immune response to some extent. It is promising to be further studied as a candidate vaccine against tuberculosis.

Construction and Identification of the Chimeric Mtb8.4/hil12 Eukaryotic Expression Plasmid

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

Construction and Identification of Recombinant Mycobacterium Smegmatis Which Expressing Fusion Gene of Heparin-Binding Haemagglutinin and Human IL12

[Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant Listeria Ivanovii].

Construction and Identification of Mycobacterium Tuberculosis Mtb8.4 Eukaryotic Expression Plasmid and Prokaryotic Expression Plasmids

Cloning and Expression of Recombinant Gene MH (Mtb8.4-Hspx) and HM (Hspx-Mtb8.4) Without Affinity Tags from Mycobacterial Tuberculosis

Construction and Identification of Recombinant BCG Carrying Human Granulysin Active Peptide and Murine IL-12 Genes

Construction and Expression of the Fused Gene Vaccine HSP65-IL-2 of Mycobacterium Tuberculosis

Expression and Purification of the Fusion Protein Comprising Mycobacterium Tuberculosis Heat Shock Protein 65 and Human Interleukin 2

Construction and identification of a Mycobacterium smegmatis strain to targetedly deliver eukaryotic coexpression plasmid encoding human granulysin and murine single chain IL-12

Expression and Identification of Rv1759c Domain of Mycobacterium Tuberculosis and IL-2 Fusion Protein

Construction of Human Single Chain Interleukin-12 Fusion Gene by Recombinant PCR

Eukaryotic Expression and Identification of Recombinant Shuttle Plasmid for Co-Expression of Human Granulysin Active Peptide and Murine IL-12

Construction,expression and gene immunization of eukaryotic expression vector containing cfp10 of Mycobacterium tuberculosis

[Construction and Expression of a Eukaryotic Vector Co-Expressing Immunodominant Antigens of CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium Tuberculosis].

Recombinant expression of multiepitope fusion polypeptide derived from Mycobacterium tuberculosis(Mtb.) antigens

Construction and Identification of LRG47/EBP50 Coexpression Plasmid

Construction of Eukaryotic Plasmid Expressing Murine Interleukin-2(mIL-2) and Analysis of Expressed Product

Construction and expression of eukaryotic plasmids containing human IL-27 protein subunits

Construction and Identification of Eukaryotic Expression Plasmid of Murine IL-3

Construction and expression of eukaryotic expression vector of Mycobacterium tuberculosis Rv2389